意大利痴呆与轻度认知障碍诊疗指南
意大利国家卫生院采用GRADE-ADOLOPMENT方法,基于英国NICE 2018年指南进行采纳、改编和更新,制定意大利首个痴呆与轻度认知障碍国家指南。
要点
- 指南覆盖从识别诊断到临终关怀的全流程,强调量身定制干预和全面认知评估。
- 强调让痴呆或轻度认知障碍患者参与决策,并全程支持家庭照护者。
- 包含167条临床实践推荐和39条研究推荐,涉及药物与非药物干预。
核心结论
- 意大利首个痴呆与轻度认知障碍国家指南旨在减少临床实践差异并确保诊疗适宜性。
- 指南强调量身定制干预、全面认知评估、员工培训和姑息治疗,并注重患者参与决策及照护者支持。
研究设计与样本
- 意大利卫生部委托意大利国家卫生院在意大利国家指南体系内制定该指南。
- 采用GRADE-ADOLOPMENT方法对英国NICE 2018年指南(NG97)进行采纳、改编和更新。
- 由29名专家和4名家庭成员/照护者代表组成的多学科小组讨论并批准了47个综述问题,其中34个来自NG97,13个为新问题(含10个关于轻度认知障碍)。
- 对每个问题进行了系统文献综述,方法学和临床专家团队基于GRADE方法对纳入研究结果进行定性评估和总结。
主要发现
- 文献覆盖领域包括:识别、诊断和诊断后支持;照护模式与协调;认知症状的药物干预;认知症状的非药物干预;非认知症状、并发疾病和姑息治疗。
- 多学科小组讨论并批准了167条临床实践推荐和39条研究推荐。
- 已开发照护路径和面向患者及家属/照护者的宣传页以促进指南实施和传播。
关键数值与推荐
- 多学科小组由29名专家和4名家庭成员/照护者代表组成,讨论并批准了47个综述问题。
- 共批准167条临床实践推荐和39条研究推荐。
临床怎么用
- 指南涵盖药物治疗和非药物治疗推荐,强调量身定制干预、全面认知评估、员工培训和姑息治疗。
- 指南强调让痴呆或轻度认知障碍患者参与决策,并在疾病全程支持照护者。
- 已提供交互式照护路径和面向患者及照护者的宣传页,可供临床实施使用。
局限性
- 指南基于英国NICE 2018年指南进行改编,部分推荐为采纳而非新制定。
- 指南计划自2027年1月开始更新,但突破性进展可能触发提前更新。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Approximately 2 million people in Italy are currently living with dementia or mild cognitive impairment (MCI), and 4 million are involved as family members or caregivers. Considering the significant impact of dementia, the Italian Ministry of Health entrusted the Italian National Institute of Health (Istituto Superiore di Sanità) with the development of a guideline within the Italian National Guideline System (Sistema Nazionale Linee Guida, SNLG) on the diagnosis and treatment of dementia and MCI. The main objective was to provide evidence-based recommendations aimed at reducing the variability and ensuring the appropriateness of clinical practices throughout the whole care process from identification and diagnosis to the end of life for people with dementia (PwD) or MCI and their families/caregivers. METHODS: The GRADE-ADOLOPMENT approach was used to adopt, adapt and update the guideline developed by the National Institute for Health and Care Excellence in 2018 (NG97). The methodology was based on the Methodological Handbook produced by the SNLG. A multidisciplinary panel of 29 experts and four representatives of family members/caregivers discussed and approved 47 review questions. Of these, 34 questions were adopted from the NG97, and 13 were new questions, including 10 questions referring to MCI. Systematic literature reviews were performed for each question, and a team of methodological and clinical experts qualitatively assessed and summarised results from included studies based on the GRADE approach. To facilitate the implementation and dissemination of the contents of this guideline, a care pathway and a leaflet dedicated to PwD or MCI and their families/caregivers were also developed. RESULTS: The literature review for this guideline included studies published up to November 2023. More than 1000 peer-reviewed publications were included, covering the following areas: (i) identification, diagnosis and post-diagnostic support; (ii) care models and care coordination; (iii) pharmacological interventions for cognitive symptoms; (iv) non-pharmacological interventions for cognitive symptoms; (v) non-cognitive symptoms, intercurrent illnesses and palliative care. The multidisciplinary panel discussed and approved 167 clinical practice recommendations and 39 research recommendations. COMMENTARY: Italy's first National Guideline on dementia and MCI addresses diagnosis, treatment and care within the National Healthcare System. It includes recommendations on pharmacological and non-pharmacological approaches, and emphasises tailored interventions, comprehensive cognitive assessment, staff training and palliative care. The guideline also underlines the need to involve PwD in decision-making and supporting caregivers throughout the entire course of the disease. CONCLUSIONS: Structured strategies for the dissemination and implementation of the guideline will be defined within the Italian Fund for Alzheimer and other Dementias 2024-2026. An interactive care pathway and a leaflet dedicated to PwD and their carers are already available. The guideline will be updated starting January 2027, but early updates may be planned in case of breakthrough advancements.
引用
- Fabrizi E, Ancidoni A, Locuratolo N, et al. The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment. Age Ageing. 2024. PMID: 39544104. doi:10.1093/ageing/afae250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。